Tag Archives: PathologyHorizons

Pathology Horizons is coming to N.Ireland

September 2018 will see Cirdan host the next Pathology Horizons conference in Northern Ireland for the first time ever.  Previous event locations have included Cairns and Fraser Island, Australia and Galway, Ireland. Pathology Horizons 2018 will be the fourth conference run by Cirdan and is to be held in the superb, five star Lough Erne Resort in County Fermanagh from 13 – 15 September.

Overview

Pathology Horizons is an annual CPD conference focused on the future of pathology and looking at what lies ahead in this area. The conference will attract expert speakers and delegates from all over the world.

Why attend?

This unique event will give delegates the chance to learn about new technologies, procedural developments and lines of research that are driving the future of pathology. They will hear about the pros and cons of these developments, how people in supporting disciplines should be preparing for and perhaps directing these changes and their potential impact on the daily work of a Pathologist.

Unlike many other events, Pathology Horizons is a boutique conference that provides an opportunity for delegates to contribute their ideas and interact with innovators from around the world, while expanding their knowledge and making some new contacts.

Who should attend?

The Pathology Horizons 2018 conference is open to anyone who is interested in the area of pathology e.g. Pathologists, Laboratory Managers and Biomedical Scientist.

Pathology Horizons 2017 Overview

The overview video of Pathology Horizons 2017 in Cairns will provide some insight into the conference content and give you a good feel for the event.

Get notified when Pathology Horizons 2018 conference registration opens.

 

Unique Conference Focused on the Future of Pathology

With two successful Pathology Horizons conferences on opposite sides of the globe under his belt and the third one due to take place next month, Dr. Hugh Cormican, Cirdan CEO opens up about the rationale for staging such an event and what delegates can expect to gain from attending.

 

Why did Cirdan start Pathology Horizons?

Cirdan has been involved in the diagnostics industry and particularly pathology since the company started in 2010. We have attended a lot of conferences and it’s very clear to us that technology and the diagnostics sector is going through huge change now, probably more than there has ever been. We found that a lot of the conferences that we attended tended to be very focused and very specific. There didn’t seem to be a forum or event focused on the future of pathology that allowed people to stand back and look at the wider picture. We didn’t see anything that highlighted what the implications for the industry are and what the implications for people like ourselves, who are a key supplier to that industry in terms of informatics systems would be. We felt that there was a gap there and that is why we set up Pathology Horizons.

Who is Pathology Horizons aimed at?

It’s aimed at all the key stakeholders in the diagnostics market, for example pathologists, laboratory managers, medical scientists and people who are suppliers to that market, including informatics companies. To date the conference has drawn a broad a mix of all disciplines interested in pathology within the diagnostics market and we would like this to continue. It’s an inclusive event, where all stakeholders can come along and share their views. We are interested in hearing their opinions on how change in the sector is going to manifest, what we need to be thinking about for the future and what the impacts of this change are likely to be.

How has the Pathology Horizons conference been received in the world of pathology?

We have received a very positive reaction so far. The people who have attended Pathology Horizons conferences have been forthcoming with praise. We started the conference on a small base and are looking to grow this and every year attendance has grown. We make the talks available online on our website for people who for whatever reason have been unable to attend the conference. We’re delighted with the extent and breadth of people who have shown interest and want to come along. Now, we’re in the very fortunate position that instead of going hunting for people to give a talk, people are coming to us offering to give presentations. I think that’s a very positive sign for the conference and the direction it’s heading in.

How have you managed to secure such a high-calibre of speaker year after year?

We hound them until they say yes. No, seriously, we attend a lot of conferences throughout the world, some we exhibit at and some we go to for our own educational or learning purposes. Therefore, we get to hear a lot of speakers give talks and see what they’re doing. If we feel they can add value to the conference and have a novel or interesting topic to share, we add them to a potential speakers list and invite them. Thankfully we’ve had a great response so far and hope this continues.

What’s planned for Pathology Horizons 2017 in Cairns?

Pathology Horizons is back in Australia this year and digital pathology is a particular area of interest there. Therefore, the conference is probably more biased towards digital pathology than it has been in previous years. We are getting a lot of interest in the subject and it is an area previous conference delegates have wanted to hear more on. Digital pathology is something that I personally have had a view on for many years. I was always of the belief that it didn’t make practical or economic sense for pathology. I held this view right up until last year. I now think that digital pathology is worth the investment. Considerable investment is needed in infrastructure i.e. hardware and software to be able to implement digital pathology in a lot of labs and I felt that it wasn’t above the gain line in terms of the work that was required. It is definitely now above the gain line. There have been some seismic changes in that the FDA have now approved it for clinical and diagnosis purposes and one of the speakers will be talking specifically about that and the impact that this has had. As well as looking at other aspects of the industry there are clearly more talks aimed at digital pathology this year.

What can delegates expect to take away from the conference?

Hopefully some surprises, some new thoughts and ideas. The conference will make delegates consider things that they hadn’t previously been thinking about or preparing for and how these will impact upon their profession. They will then leave better placed to prepare for these changes and in a position of knowledge to find out more.

The conference will provide an opportunity to network not only with other delegates but with the speakers. We just have one conference stream, so everyone will have the opportunity to get involved, give feedback and ask questions. At Pathology Horizons, everyone is part of the discussion on the future of pathology.

View Agenda

Register Now

Dr. Pantanowitz to speak on computer aided diagnosis at Pathology Horizons

This August in Cairns Pathology Horizons delegates will have the privilege of hearing Dr. Liron Pantanowitz delivering a talk on the pros and cons of computer aided diagnosis in pathology.

Artificial Intelligence (AI) is becoming a reality in medicine. However, can these deep learning tools perform the complex tasks of pathologists, and in some instances with superior accuracy? Image analysis is one of the main reasons pathology labs are thinking about investing in digital pathology, especially since precision medicine currently demands precision diagnostics.

Enough evidence has been accrued showing that image analysis offers better accuracy, standardization, automation, and enables computational pathology. However, there are still several drawbacks and barriers preventing widespread adoption such as limited interoperability, workflow disruption, poor reimbursement, no guidelines, and regulatory obstacles.

During his presentation Dr. Pantanowitz will discuss the benefits and problems related to computer aided diagnosis in pathology and will highlight what is required to deliver those awaited killer apps.

Dr. Liron Pantanowitz is currently a Professor of Pathology and of Biomedical Informatics at the University of Pittsburgh in the USA.

He is the Director of the Pathology Informatics Division and Director of the Pathology Informatics Fellowship at the University of Pittsburgh Medical Center (UPMC). In additon, he is the Director of the Cytopathology Division at UPMC Shadyside.

More on Dr. Liron Pantanowitz

View Agenda

Register now

Dr. Kaplan to discuss Digital Pathology: The Past, Present and Future at Pathology Horizons

We are thrilled to have Dr. Keith Kaplan, publisher of tissuepathology.com, the industry’s leading digital pathology blog speak at this year’s Pathology Horizons conference in Cairns, Australia from 10th -12th August.

During his presentation Dr. Kaplan will reflect on 15 years of digital pathology, what has worked, what hasn’t and what’s coming. He will focus briefly on historical experience and initial use cases, how changes that are happening to pathology impact business operations, making a business case for digital pathology and why the time is now to adopt digital pathology. Mention of the importance/impact of cloud computing, hand-held computing and social media that coincided with maturation of this technology will also be discussed. The need for image analysis with clinically approved protocols for improved consistency and reproducibility particularly in an era when the use of companion diagnostics will be addressed. More recently, significant changes in healthcare delivery systems and reimbursements for technical and professional services for laboratories and pathologists have started to change the landscape that make digital pathology more attractive than in the past 15 years.

Dr. Kaplan is a native of Chicago and a graduate of Michigan State University and Northwestern University Feinberg School of Medicine. He completed residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC.

More on Dr. Keith Kaplan

View Pathology Horizons Agenda

Register now

Hear about Novel Microscopies from Prof. Richard Levenson

We are pleased to announce that Prof. Richard Levenson will be joining us in Cairns this August for the annual Pathology Horizons Conference.

The title of Prof. Levenson’s talk is “Path, Present and Future: Novel Microscopies” .

According to Prof. Levenson how microscopes work in actual clinical pathology has not changed materially in well over a century. Recently, however, a number of new approaches are being developed, some of which will eventually find their way into the mainstream. One method, which Prof. Levenson will look at in detail is Microscopy with Ultraviolet Surface Excitation (MUSE). MUSE is a rapid approach for obtaining high-resolution, diagnostic quality histological images from unsectioned thick tissue specimens, replacing the need for slide preparation and the attendant extensive tissue processing and thin physical sectioning. MUSE is notable for its optical and mechanical simplicity. Excitation of tissue surfaces with 280-nm UV excitation excites a wide range of exogenous dyes with very large Stokes shifts. The resulting images can be captured using ordinary microscopic optics and standard CMOS or CCD cameras.

Preparing a sample for MUSE imaging can be performed in around a minute. With appropriate stage travel, extended fields of view can be captured from whole organs with microscopic detail. This non-destructive process leaves the sample intact for subsequent downstream molecular or genetic analysis.

In addition, images can include shading and depth cues that reveal surface profiles important in understanding the three-dimensional organization of complex specimens. This inexpensive, rapid and slide-free, sample-sparing method has potential to replace frozen sections, and may have other applications in both high and  low resource settings.

Here’s a snippet of Prof. Levenson speaking about the ground breaking topic of MUSE.

Join us for Pathology Horizons 2017 in Cairns to hear more.

View Prof. Richard Levenson’s bio

Register now

David Bottoms to speak on Pathology Digital Imaging in the UK

We are delighted to have David Bottoms speaking at the Pathology Horizons Conference in Cairns, Australia this August.

During his presentation entitled, “Pathology Digital Imaging in the UK – Are we nearly there yet?” he will provide delegates with insight into the scope, objectives and findings of a Digital Imaging Proof of Concept study undertaken in the UK. David is able to provide both a project management and pathologist perspective and his talk will include the key elements of the business case for digital imaging.

David has been a part of service integration and a variety of pathology projects spanning the North and South of the UK since the turn of the century.

He continues to work for the NHS in a variety of roles, including work for the North of England Cancer Care Alliance, Pathology project across West Yorkshire and the Digital Imaging project in Leeds.

Since 2014 he has been involved in the promotion of Pathology Digital Imaging as part of a wider potential solution to address service risks/ resilience in the face of workload/ workforce imbalance within Cellular Pathology services and sincerely hopes that he will help catalyse the progression of Digital Imaging not just in his own patch but elsewhere across the UK.

See David Bottom’s bio and read an abstract of his talk.

View Pathology Horizons 2017 agenda.

Register for Pathology Horizons

Prof. Leslie Burnett will be talking ‘Genomics’ at Pathology Horizons 2017

Wprof-leslie-burnette are delighted to announce that Professor Leslie Burnett will be speaking at the Pathology Horizons 2017 Conference in Cairns this August.

Prof. Burnett will be presenting on:

“Bringing Genomics into Mainstream Medical Practice”

Prof. Burnett believes the introduction of clinically accredited Whole Genome Sequencing and the increasing availability of genomic  technologies is heralding a new era for modern medicine.

According to Dr. Burnett, these transformative techniques are more than new tests: their implementation offers huge potential for improving patient care and preventative health but challenge existing systems of test requesting, patient consent, result reporting, and clinical consultation.

In his presentation Dr. Burnett will describe the scope and range of medicine that are already being changed through the ready availability of genomics, and will provide examples of some of the surprisingly simple solutions that are being developed to support the introduction of genomics into medical practice.”

Prof. Burnett is Chief Medical Officer of Genome.One, a wholly owned subsidiary of the Garvan Institute of Medical Research. He is a passionate teacher and communicator about the genetics and genomics revolution.

Read more on Prof. Leslie Burnett

View conference Agenda

Register for Pathology Horizons 2017

We welcome Dr. Miguel N. Burnier Jr. to the Pathology Horizons Speaker Panel

Dr. Miguel N. Burnier Jr.We are pleased to announce our Canadian addition to the Pathology Horizons 2017 Speaker Panel.

Dr. Burnier’s field of study is Ophthalmology.  Dr. Burnier was the Chairman of the Department of Ophthalmology, McGill University, from 1993 to 2008 along with being a full Professor of Ophthalmology, Pathology, Medicine and Oncology at McGill.

Dr. Burnier is presenting :

“The Use of Digital Pathology in Ocular Pathology: Advantages of automated analysis”.  

Ocular pathology is a distinct sub specialty of anatomical pathology and in many instances ocular pathologists receive consultations from outside their hospital. Digital pathology plays a crucial role in this process. Particularly in Ocular Pathology, the difference between the analysis of selected images compared to the whole slide image is crucial.

See Miguel Burnier’s bio and read an abstract of his talk.

More on conference speakers.

To register your interest in attending and to request a copy of the conference programme (when it becomes available) contact Elaine at earmstrong@cirdan.com

Dr. Michael Legg joins Pathology Horizons 2017!  Hear his take on Combining Radiology and Pathology…

michael-leggbWe are pleased to announce that Dr. Michael Legg will be joining our speaker panel at the Pathology Horizons Conference from 10-12th August in Cairns, Australia.

As a Consultant Health Informatician, Dr. Legg is an expert on organisational systems and informatics. With this wide knowledge base, he is focusing his talk on

“Why advances In Biology and Informatics should bring Pathology and Radiology together into a combined diagnostics discipline”.

He is interested in the extent of diagnostic error and how poor diagnosis can be harmful to patient satisfaction.  He believes combining radiology and pathology is an integral part to improve this, in addition, being good for politics and business reasons. He believes this merger between the two disciplines is inevitable but needs to be better managed.

See Dr. Michael Legg’s bio and read an abstract of his talk.

More on conference speakers.

To register your interest in attending and to request a copy of the conference programme (when it becomes available) contact Elaine at earmstrong@cirdan.com.

Prof Anthony Gill to speak “Morphologomics” at Pathology Horizons 2017

We are delgill_photograph192-252ighted to announce that Prof Anthony Gill will be part of our speaker panel for the Pathology Horizons Conference in Cairns, Australia from 10th – 12th August.

He is one of many experts who will discuss the future of pathology at this  annual event.

Prof Gill’s talk titled,

“Morphologomics – Challenges for Surgical Pathology in the Genomic Age”

discusses how basic morphological approaches in the diagnostic surgical pathology laboratory have not changed in more than 100 years while other pathology disciplines, from haematology to genomics, have undergone tremendous automation practices. Prof. Gill will introduce and discuss the concept of ‘Morphologomics’, that is omics approaches critically reimagined and reappraised from the viewpoint of classic morphology.

Prof. Gill’s research mainly focuses on translating advances in knowledge gained at the basic science level into clinically useful diagnostic tests including classic morphology.

Prof. Gill is a Senior Staff Specialist in Anatomical Pathology at Royal North Shore in Sydney.

See Anthony Gill’s bio and read an abstract of his talk.

View Agenda

Register for Pathology Horizons 2017